← FDA DRUG APPROVALS

FDA ANDA · ANDA062030

AMCILL

Sponsor: PARKE DAVIS

APPLICATION
ANDA062030
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

AMCILLDiscontinued
AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML · FOR SUSPENSION · ORAL
AMCILLDiscontinued
AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML · FOR SUSPENSION · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →